During the past decade, UCLA Stroke Network conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCLA Stroke Network" are "Stroke" (2 trials). Many other conditions were trialed in "UCLA Stroke Network" in a lesser frequency.

Most popular intervention types in "UCLA Stroke Network" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "V10153" (1 trials), "piclozotan high dose" (1 trials), "piclozotan low dose" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Stroke Network" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Stroke Network". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UCLA Stroke Network, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Stroke Network, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".